UniProt ID | ACSL5_HUMAN | |
---|---|---|
UniProt AC | Q9ULC5 | |
Protein Name | Long-chain-fatty-acid--CoA ligase 5 | |
Gene Name | ACSL5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 683 | |
Subcellular Localization |
Mitochondrion. Endoplasmic reticulum. Mitochondrion outer membrane Single-pass type III membrane protein. Endoplasmic reticulum membrane Single-pass type III membrane protein. |
|
Protein Description | Acyl-CoA synthetases (ACSL) activate long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL5 may activate fatty acids from exogenous sources for the synthesis of triacylglycerol destined for intracellular storage (By similarity). Utilizes a wide range of saturated fatty acids with a preference for C16-C18 unsaturated fatty acids (By similarity). It was suggested that it may also stimulate fatty acid oxidation (By similarity). At the villus tip of the crypt-villus axis of the small intestine may sensitize epithelial cells to apoptosis specifically triggered by the death ligand TRAIL. May have a role in the survival of glioma cells.. | |
Protein Sequence | MLFIFNFLFSPLPTPALICILTFGAAIFLWLITRPQPVLPLLDLNNQSVGIEGGARKGVSQKNNDLTSCCFSDAKTMYEVFQRGLAVSDNGPCLGYRKPNQPYRWLSYKQVSDRAEYLGSCLLHKGYKSSPDQFVGIFAQNRPEWIISELACYTYSMVAVPLYDTLGPEAIVHIVNKADIAMVICDTPQKALVLIGNVEKGFTPSLKVIILMDPFDDDLKQRGEKSGIEILSLYDAENLGKEHFRKPVPPSPEDLSVICFTSGTTGDPKGAMITHQNIVSNAAAFLKCVEHAYEPTPDDVAISYLPLAHMFERIVQAVVYSCGARVGFFQGDIRLLADDMKTLKPTLFPAVPRLLNRIYDKVQNEAKTPLKKFLLKLAVSSKFKELQKGIIRHDSFWDKLIFAKIQDSLGGRVRVIVTGAAPMSTSVMTFFRAAMGCQVYEAYGQTECTGGCTFTLPGDWTSGHVGVPLACNYVKLEDVADMNYFTVNNEGEVCIKGTNVFKGYLKDPEKTQEALDSDGWLHTGDIGRWLPNGTLKIIDRKKNIFKLAQGEYIAPEKIENIYNRSQPVLQIFVHGESLRSSLVGVVVPDTDVLPSFAAKLGVKGSFEELCQNQVVREAILEDLQKIGKESGLKTFEQVKAIFLHPEPFSIENGLLTPTLKAKRGELSKYFRTQIDSLYEHIQD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
28 (in isoform 3) | Phosphorylation | - | 3.25 | 26657352 | |
32 (in isoform 3) | Phosphorylation | - | 1.76 | 17192257 | |
62 | Ubiquitination | ARKGVSQKNNDLTSC CCCCCCCCCCCCCHH | 50.65 | 27667366 | |
96 | Phosphorylation | DNGPCLGYRKPNQPY CCCCCCCCCCCCCCC | 11.52 | 119477 | |
98 | Ubiquitination | GPCLGYRKPNQPYRW CCCCCCCCCCCCCEE | 39.58 | 27667366 | |
107 | O-linked_Glycosylation | NQPYRWLSYKQVSDR CCCCEEEEEEEHHCH | 24.27 | 30397120 | |
117 | Phosphorylation | QVSDRAEYLGSCLLH EHHCHHHHHHHHHHC | 18.51 | 29759185 | |
118 | Ubiquitination | VSDRAEYLGSCLLHK HHCHHHHHHHHHHCC | 2.83 | 27667366 | |
127 | Phosphorylation | SCLLHKGYKSSPDQF HHHHCCCCCCCHHHE | 16.70 | 29759185 | |
154 | Ubiquitination | ISELACYTYSMVAVP HHHHHHHHHCCCEEE | 14.70 | 27667366 | |
163 | Phosphorylation | SMVAVPLYDTLGPEA CCCEEEHHHCCCHHH | 10.79 | 12306821 | |
200 (in isoform 1) | Ubiquitination | - | 55.85 | 21890473 | |
200 | Ubiquitination | VLIGNVEKGFTPSLK EEECCCCCCCCCCEE | 55.85 | 21906983 | |
220 (in isoform 1) | Ubiquitination | - | 44.97 | 21890473 | |
220 | Ubiquitination | DPFDDDLKQRGEKSG CCCCHHHHHHCHHCC | 44.97 | 21906983 | |
225 (in isoform 1) | Ubiquitination | - | 57.73 | 21890473 | |
225 | Ubiquitination | DLKQRGEKSGIEILS HHHHHCHHCCEEEEE | 57.73 | 21906983 | |
234 | Phosphorylation | GIEILSLYDAENLGK CEEEEEEECHHHHCC | 15.10 | 24425373 | |
241 | Ubiquitination | YDAENLGKEHFRKPV ECHHHHCCHHCCCCC | 51.70 | 21906983 | |
241 | "N6,N6-dimethyllysine" | YDAENLGKEHFRKPV ECHHHHCCHHCCCCC | 51.70 | - | |
241 (in isoform 1) | Ubiquitination | - | 51.70 | 21890473 | |
241 | Methylation | YDAENLGKEHFRKPV ECHHHHCCHHCCCCC | 51.70 | - | |
246 | Ubiquitination | LGKEHFRKPVPPSPE HCCHHCCCCCCCCHH | 49.80 | 23503661 | |
256 | Ubiquitination | PPSPEDLSVICFTSG CCCHHHCEEEEEECC | 23.04 | 23503661 | |
256 (in isoform 3) | Ubiquitination | - | 23.04 | - | |
276 | Ubiquitination | KGAMITHQNIVSNAA CCCEEECHHHHHHHH | 32.47 | 23503661 | |
276 (in isoform 3) | Ubiquitination | - | 32.47 | - | |
281 | Ubiquitination | THQNIVSNAAAFLKC ECHHHHHHHHHHHHH | 23.78 | 23503661 | |
281 (in isoform 3) | Ubiquitination | - | 23.78 | - | |
293 | Phosphorylation | LKCVEHAYEPTPDDV HHHHHHHCCCCCCHH | 25.09 | 25332170 | |
296 | Phosphorylation | VEHAYEPTPDDVAIS HHHHCCCCCCHHHHH | 27.66 | 25332170 | |
297 (in isoform 3) | Ubiquitination | - | 46.66 | - | |
297 | Ubiquitination | EHAYEPTPDDVAISY HHHCCCCCCHHHHHH | 46.66 | 23503661 | |
302 | Ubiquitination | PTPDDVAISYLPLAH CCCCHHHHHHHHHHH | 2.53 | 23503661 | |
320 | Phosphorylation | RIVQAVVYSCGARVG HHHHHHHHHCCCCCE | 7.52 | 25332170 | |
341 | Ubiquitination | RLLADDMKTLKPTLF HHHHHHHHHHCCCHH | 58.67 | 23503661 | |
344 | Ubiquitination | ADDMKTLKPTLFPAV HHHHHHHCCCHHHHH | 40.98 | 21906983 | |
344 (in isoform 1) | Ubiquitination | - | 40.98 | 21890473 | |
359 | Phosphorylation | PRLLNRIYDKVQNEA HHHHHHHHHHHHHHC | 13.38 | 28152594 | |
361 | Ubiquitination | LLNRIYDKVQNEAKT HHHHHHHHHHHHCCC | 28.84 | 27667366 | |
361 | Acetylation | LLNRIYDKVQNEAKT HHHHHHHHHHHHCCC | 28.84 | - | |
367 | Ubiquitination | DKVQNEAKTPLKKFL HHHHHHCCCHHHHHH | 44.49 | 27667366 | |
380 | Phosphorylation | FLLKLAVSSKFKELQ HHHHHHHHHHHHHHH | 23.39 | 46158103 | |
381 | Phosphorylation | LLKLAVSSKFKELQK HHHHHHHHHHHHHHH | 35.20 | 113334121 | |
388 | Ubiquitination | SKFKELQKGIIRHDS HHHHHHHHCCCCCCC | 65.78 | 27667366 | |
395 | Phosphorylation | KGIIRHDSFWDKLIF HCCCCCCCHHHHHHH | 23.32 | 27067055 | |
397 | Ubiquitination | IIRHDSFWDKLIFAK CCCCCCHHHHHHHHH | 13.04 | 23503661 | |
397 (in isoform 3) | Ubiquitination | - | 13.04 | - | |
399 | Ubiquitination | RHDSFWDKLIFAKIQ CCCCHHHHHHHHHHH | 33.79 | 22817900 | |
400 (in isoform 3) | Ubiquitination | - | 3.45 | - | |
400 | Ubiquitination | HDSFWDKLIFAKIQD CCCHHHHHHHHHHHH | 3.45 | 27667366 | |
404 (in isoform 4) | Ubiquitination | - | 30.10 | 21890473 | |
404 | Ubiquitination | WDKLIFAKIQDSLGG HHHHHHHHHHHHCCC | 30.10 | 22817900 | |
404 (in isoform 1) | Ubiquitination | - | 30.10 | 21890473 | |
404 | Ubiquitination | WDKLIFAKIQDSLGG HHHHHHHHHHHHCCC | 30.10 | 21890473 | |
408 | Phosphorylation | IFAKIQDSLGGRVRV HHHHHHHHCCCCEEE | 16.73 | 69338895 | |
417 | Ubiquitination | GGRVRVIVTGAAPMS CCCEEEEEECCCCCC | 3.55 | 27667366 | |
417 (in isoform 3) | Ubiquitination | - | 3.55 | - | |
418 | Phosphorylation | GRVRVIVTGAAPMST CCEEEEEECCCCCCH | 15.24 | 28509920 | |
423 | Ubiquitination | IVTGAAPMSTSVMTF EEECCCCCCHHHHHH | 6.14 | 27667366 | |
424 | Phosphorylation | VTGAAPMSTSVMTFF EECCCCCCHHHHHHH | 19.23 | 28509920 | |
425 | Phosphorylation | TGAAPMSTSVMTFFR ECCCCCCHHHHHHHH | 21.06 | 28509920 | |
444 | Ubiquitination | CQVYEAYGQTECTGG CCEEEECCCEECCCC | 34.67 | 27667366 | |
455 | Ubiquitination | CTGGCTFTLPGDWTS CCCCCEEECCCCCCC | 17.56 | 22817900 | |
460 | Ubiquitination | TFTLPGDWTSGHVGV EEECCCCCCCCCCCC | 9.81 | 21890473 | |
460 (in isoform 3) | Ubiquitination | - | 9.81 | 21890473 | |
498 | Phosphorylation | GEVCIKGTNVFKGYL CCEEEECCEEECCCC | 24.17 | 26074081 | |
502 | Ubiquitination | IKGTNVFKGYLKDPE EECCEEECCCCCCHH | 42.22 | 23503661 | |
504 | Phosphorylation | GTNVFKGYLKDPEKT CCEEECCCCCCHHHH | 15.92 | 26074081 | |
506 (in isoform 1) | Ubiquitination | - | 63.85 | 21890473 | |
506 | Ubiquitination | NVFKGYLKDPEKTQE EEECCCCCCHHHHHH | 63.85 | 21906983 | |
510 | Ubiquitination | GYLKDPEKTQEALDS CCCCCHHHHHHHHHC | 61.98 | 23503661 | |
511 | Phosphorylation | YLKDPEKTQEALDSD CCCCHHHHHHHHHCC | 29.94 | 69011261 | |
546 | Ubiquitination | DRKKNIFKLAQGEYI ECCCCCHHHHCCCCC | 38.83 | 27667366 | |
552 | Phosphorylation | FKLAQGEYIAPEKIE HHHHCCCCCCHHHHH | 14.81 | 25884760 | |
557 (in isoform 1) | Ubiquitination | - | 55.02 | 21890473 | |
557 | Ubiquitination | GEYIAPEKIENIYNR CCCCCHHHHHHHHCC | 55.02 | 21906983 | |
558 | Ubiquitination | EYIAPEKIENIYNRS CCCCHHHHHHHHCCC | 4.70 | 23503661 | |
562 (in isoform 3) | Ubiquitination | - | 18.99 | - | |
562 | Ubiquitination | PEKIENIYNRSQPVL HHHHHHHHCCCCCEE | 18.99 | 23503661 | |
566 | Ubiquitination | ENIYNRSQPVLQIFV HHHHCCCCCEEEEEE | 28.96 | 23503661 | |
580 | Phosphorylation | VHGESLRSSLVGVVV EECHHHHHHCCEEEE | 33.06 | 37817023 | |
581 | Phosphorylation | HGESLRSSLVGVVVP ECHHHHHHCCEEEEC | 22.20 | 21406692 | |
595 | Phosphorylation | PDTDVLPSFAAKLGV CCCCCHHHHHHHHCC | 24.29 | 20071362 | |
599 | Ubiquitination | VLPSFAAKLGVKGSF CHHHHHHHHCCCCCH | 42.20 | 2190698 | |
599 (in isoform 1) | Ubiquitination | - | 42.20 | 21890473 | |
602 | Ubiquitination | SFAAKLGVKGSFEEL HHHHHHCCCCCHHHH | 10.33 | 27667366 | |
603 | Ubiquitination | FAAKLGVKGSFEELC HHHHHCCCCCHHHHH | 47.22 | 27667366 | |
605 | Phosphorylation | AKLGVKGSFEELCQN HHHCCCCCHHHHHHC | 24.62 | 30624053 | |
628 | Ubiquitination | EDLQKIGKESGLKTF HHHHHHCHHHCCCHH | 52.78 | 27667366 | |
634 | Phosphorylation | GKESGLKTFEQVKAI CHHHCCCHHHHHHHH | 37.13 | 37278147 | |
656 | Phosphorylation | SIENGLLTPTLKAKR EECCCCCCHHEECCC | 21.19 | 27067055 | |
659 | Ubiquitination | NGLLTPTLKAKRGEL CCCCCHHEECCCCHH | 5.52 | 27667366 | |
678 | Phosphorylation | RTQIDSLYEHIQD-- HHHHHHHHHHHCC-- | 14.93 | 20732281 | |
684 | Ubiquitination | LYEHIQD-------- HHHHHCC-------- | 27667366 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ACSL5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ACSL5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACSL5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ACSL5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...